ADMA Biologics Announces Proposed $75 Million Public Offering of Common Stock

NEXT STORY
2019 Membrane and Separation Technology Research Review
PREV STORY
Myriad Genetics Reports Fiscal Second-Quarter 2020 Financial Results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

FIT Biotech Oy: Conversion of FIT Biotech Oy’s Convertible Capital Notes into shares

FIT Biotech Oy Company release November 6, 2017 at 10:00 AM EET Conversion of ...

author_avatar
NASDAQ Market News

Veterinary Equipment & Disposables Market to touch US$ 2,494.2 million by 2026 – TMR

Veterinary Equipment & Disposables Market: Critical Care Consumables Segment Dominated the MarketAlbany, New York, ...

author_avatar
NASDAQ Market News

EyeGate Submits Investigational Device Exemption (IDE) Filing for Second Pilot Study of Ocular Bandage Gel

WALTHAM, Mass., May 04, 2017 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) (“EyeGate” or ...

author_avatar
NASDAQ Market News